Carisma Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!

About CARM

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. 

CEO
Steven Kelly
CEOSteven Kelly
Employees
46
Employees46
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2016
Founded2016
Employees
46
Employees46

CARM Key Statistics

Market cap
2.03M
Market cap2.03M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
511.93K
Average volume511.93K
High today
$0.054
High today$0.054
Low today
$0.0455
Low today$0.0455
Open price
$0.0484
Open price$0.0484
Volume
188.61K
Volume188.61K
52 Week high
$1.27
52 Week high$1.27
52 Week low
$0.0261
52 Week low$0.0261

People also own

Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Cenntro Inc.
NIO
Tilray Brands
Lucid Group
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.